The reality of adherence to rhinitis treatment: Identifying and overcoming the barriers
Don A. Bukstein(Institute for Asthma and Allergy), Judith R. Farrar, Allan T. Luskin(Dean Health Systems)
Cited by 33
Related Papers
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
|The Journal of Allergy and Clinical Immunology In Practice|2018|277
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
|The Journal of Allergy and Clinical Immunology In Practice|2020|119
Digital Health Technology in Asthma: A Comprehensive Scoping Review
|The Journal of Allergy and Clinical Immunology In Practice|2021|119